WHO-Recommended Tuberculosis Treatment Shows Comparable Efficacy and Safety in South Korean Patients
AI 요약 정보
- South Korean study finds WHO regimen comparable to alternative
- 12-month recurrence-free: 70.9% with quinolone, 72.7% without
- Observational study of 99 patients; larger studies needed
